NewTimeSpace News: On June 26, 2026, BIDU-SW(09888.HK) trended downwards amid volatility during morning trading. As of 11:33, its intraday price stood at HK$98.70, representing a 4.55% decline. The global market size for L4 and higher-level autonomous driving reached US$1 billion in 2024 and is projected to hit US$1.464 trillion by 2030.
Henlius (2696.HK) announced that the European Commission approved serplulimab (Hansizhuang®/HETRONIFLY®) in combination with carboplatin and nab-paclitaxel for first-line treatment of adult patients with unresectable locally advanced or metastatic sqNSCLC, applicable across all EU member states and EEA countries; the approval was based on a randomized, double-blind, international multi-center Phase 3 study showing significant benefit and good safety, following EU GMP certification in December 2023 and a positive CHMP opinion in May 2026; serplulimab is now approved in China, the EU, UK and multiple Southeast Asian countries, with the global PD-1 mAb market reaching approximately USD50.871 billion in 2025.
NewTimeSpace News: CStone Pharmaceuticals (02616.HK) announced an exclusive commercialization cooperation agreement with Arrotex Pharmaceuticals, the core commercial platform under Australia’s diversified pharmaceutical and healthcare group DBG Health, for Sugemalimab in Australia and New Zealand. CStone will receive an upfront payment, subsequent registration and sales milestone payments, plus a share of revenues generated within the licensed territories. The commercial footprint of Sugemalimab now covers more than 60 countries and regions globally.
NewTimeSpace News: CanSino Biologics announced on June 25 that its Group A, C, Y and W135 Meningococcal Conjugate Vaccine (MCV4, trade name: Menhyxin®) has obtained a registration certificate issued by Argentina’s National Administration of Medicines, Food and Medical Devices.
On June 25, Hong Kong tech stocks hit one-year lows, yet the LLM and domestic computing power sectors staged a counter-trend rally, led by ZHIPU AI climbing over 8% and Biren Technology reaching an all-time high via DeepSpeed integration. Crucial industry breakthroughs emerged: five Chinese ministries jointly launched an action plan to accelerate end-to-end autonomous driving and transport AI solutions; OpenAI partnered with Broadcom to debut its first custom inference ASIC, "Jalapeño," boasting a rapid 9-month tape-out; and Baidu AI Cloud rolled out its Qianfan Token Plan Enterprise Edition, pioneering access to ZHIPU's GLM-5.2.
NewTimeSpace News: On June 25, 2026, RoboSense (02498.HK) trended weaker in the afternoon trading session. As of 14:22, its intraday quotation stood at HK$21.32, representing a drop of 3.44%. The large-scale commercial adoption of high-level intelligent driving is expected to pick up speed.
NewTimeSpace (newtimespace.com) News: On June 25, 2026, the chip sector continued to strengthen. ASMPT(00522.HK) opened higher and fluctuated. As of 13:38 PM, the company's share price was quoted at HK$202.200, up 0.70%.
NewTimeSpace (newtimespace.com) News: On June 25, 2026, the humanoid robot sector weakened.Xiaomi-W (01810.HK) fluctuated and weakened. As of 13:13 PM, the company's share price was quoted at HK$22.200, down 3.31%.
NewTimeSpace (newtimespace.com) News, The inaugural Beijing-Birmingham Technology Week was held in Beijing, and Mininglamp Technology (2718.HK) was one of the four Beijing sci-tech enterprises invited to participate in the event. The company expressed its willingness to enter the UK market and deepen industrial cooperation, and secured the opportunity to participate in the main event of Birmingham Tech Week this October.
NewTimeSpace (newtimespace.com) News: On June 25, 2026, despite the weakening of the Hang Seng Tech Index, Hong Kong's artificial intelligence-themed stocks bucked the trend to strengthen. Zhipu (2513.HK) led the gains; as of 9:50 AM, the company's share price was quoted at HK$2,352.000, up 8.19%.
NewTimeSpace News: HUTCHMED announced on June 25 that results from its pivotal Phase II registrational study of fisogatinib for the treatment of intrahepatic cholangiocarcinoma are set to be unveiled at the 2026 ESMO Gastrointestinal Cancers Congress.
NewTimeSpace News: Mabwell announced on June 24 that the clinical trial application for its self-developed Injection 9MW5211 for the indication of multiple sclerosis (MS) has been approved by the National Medical Products Administration (NMPA).
Mabpharm (2181.HK) announced that its pipeline product CMAB807X Leishu® (denosumab injection) has received NMPA approval for its NDA, with indications covering the treatment of solid tumor bone metastasis or multiple myeloma patients to delay or reduce skeletal-related event risks, and giant cell tumor of bone that is unresectable or where surgery would cause severe morbidity, including adults and skeletally mature adolescents.
On June 24, Hong Kong stocks fluctuated higher, driven by a broad rally in the semiconductor sector, where Hua Hong Semiconductor skyrocketed over 15% to an all-time high following acquisition approvals. AI application stocks diverged: Tencent advanced 3.4% as its WeCom AI Agent entered closed beta, while MiniMax continued to decline. Industry developments highlighted that over 900 large models are now operational in China, with regulators drafting new AI agent guidelines. Meanwhile, Alibaba launched Qwen-AgentWorld, the first native language world model, and Mininglamp rolled out its "Agent Ready" solution, integrating with WeChat and Qwen to accelerate enterprise AI commercialization.
NewTimeSpace (newtimespace.com) News: On June 24, 2026, the chip sector strengthened as SMIC (00981.HK) surged significantly. As of 13:21 PM, the company's share price was quoted at HK$85.600, up 9.96%.
NewTimeSpace (newtimespace.com) News:On June 24, 2026, the humanoid robot sector fluctuated and weakened. UBTECH (09880.HK) fluctuated downward, with the company's share price quoted at HK$97.950, edging down by 0.05% as of 13:09 PM.
